Elisa Giovannetti

DR., (Principal Investigator)


Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Licensure and certification

  • Scientific Habilitation as Full Professor of Pharmacology, Italian Ministry of Education, University and Research (ASN, MIUR 2022, June 17th): Evaluation: “the 3 bibliometric parameters are all far above the requested medians, and the candidate has all the 6 parameters requested by the committee (1 – Organization and attendance as invited speakers to scientific meetings in Italy and abroad, 2 – Direction of a research group with national and international collaborations, 3 – Responsibility of studies and researches funded by public and private institutions, 4 - Responsibility of research projects funded within competitive national and international grants; 5 – Teaching or fellowships in international Universities or Scientific Institutions; 6 – Patents)
  • BASIC QUALIFICATION IN EDUCATION (BKO qualification), obtained after successfully applying to the course Fast-track University Teaching Programme (Fast-track UTP), on the 12th April 2018 (in The Netherlands all members of staff (with a University Job Classification (Universitair Functieordenen, UFO) as teacher, lecturer, senior lecturer or professor) who provide scientific education to University students are required to obtain the University Teaching Qualification (BKO certificate)).

    The final assessment reported: “Dr. Giovannetti is a serious and dedicated academic teacher. She is knowledgeable and flexible, and acts as a role academic model for her students.

  • Associate Professor of Pharmacology, UHD, Dept. LabMO, VUmc
  • Scientific Habilitation as Associate Professor of Pharmacology, Italian Ministry of Education, University and Research (ASN, MIUR, January 2012). Evaluation: “The candidate Elisa GIOVANNETTI exceeds the requested medians in bibliometric parameters in 3/3 categories. The candidate's research addresses key aspects of cancer research and shows excellent productivity, quality and continuity
  • PhD in Internal Medicine and Pharmacology, University of Pisa (Thesis: Preclinical studies and pharmacogenetics of gemcitabine and pemetrexed in pancreas and lung cancer) (2000 - 2007)
  • Postgraduate Master in “Clinical and Experimental Pharmacology”, University of Pisa, 2005
  • Board-certified Clinical Pharmacologist, University of Pisa, Pisa, Italy (2004)
  • MD, School of Medicine, University of Pisa, Pisa, Italy, magna cum laude and thesis (In vitro and in vivo studies on antitumoral activity of ceramide analogs) publication (1993 – 2000

External positions

Chair PAMM group, European Organization for Research and Treatment of Cancer (EORTC), Netherlands

1 Jun 20211 Jun 2024

PI (senior scientific researcher), Fondazione Pisana per la Scienza-ONLUS, Pisa, Italy

1 Feb 20211 Feb 2026

Deputy Editor - Critical Reviews Oncology and Hematology, Elsevier, Amsterdam, Netherlands

1 Dec 20181 Dec 2028


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or